People are sleeping on how fast solving death becomes humanity's focus.
Anthropic will develop its own drugs in-house to test and refine its Claude Science laboratory AI model
Story Overview
Anthropic is launching an internal preclinical drug discovery effort aimed at neglected and rare diseases, explicitly to gather real lab experience that will feed back into its newly released Claude Science workbench for scientists.
The in-house loop they're building
Executives frame the move as a way to live the same workflows they sell to pharma partners rather than theorize from the outside, starting only at the earliest research stages.
What stays off the table for now
No specific disease targets, timelines, or plans for clinical trials have been shared, leaving the path from preclinical work to any patient impact entirely open.
Positive users praise Anthropic entering drug development with Claude for accelerating science and longevity timelines, while negative users criticize it for competing with customers and obsessing over unfair longevity gains.
No Digg Deeper questions have been answered for this story yet.
Most Activity
Anthropic wants to make its own drugs with help from Claude.
Claude Science is meant to do for lab research what Claude Code did for programming.
Drug discovery is messier, because molecules fail when biology, chemistry, safety, or dosing breaks.
Anthropic wants its researchers to feel those failures directly while shaping the product.
The first programs will target neglected diseases, including rare disorders and some tropical conditions.
These areas often have clearer biology but weaker commercial incentives than common diseases.
Many rare genetic disorders start with one broken gene, giving AI a cleaner target.
Common conditions usually involve many genes, tissues, histories, and environments interacting at once.
That difference makes early rare-disease work a harder business, but a clearer testbed.
Anthropic also avoids competing with pharma customers by choosing overlooked programs.
Anthropic already works closely with major drugmakers, so it understands where researchers get stuck.
Novartis CEO Vas Narasimhan joining the board gives those product decisions direct pharma-level pressure.
Anthropic bought Coefficient Bio and hired AlphaFold researcher John Jumper, so this is not a side experiment. Shows how seriously Anthropic is treating biology.
---
statnews. com/2026/06/30/anthropic-ai-drug-development/

@bryan_johnson AI is still pushing contaminated, cancer causing COVID-19 Vaccines, so no, AI isn't solving anything 😂

@Steven_Hari I suspect that we will find some stunning early wins but there will be a few hold out problems that take us into the late 2030s to see meaningful progress.

@bryan_johnson You still on track for 2039 ?

@bryan_johnson Why are we so focused on not dying when so many people aren’t living…like you @bryan_johnson you’re chasing immortality but could get hit my a truck tomorrow all for what? To live an automated life with little spontaneity and wonder?

@bryan_johnson Good luck, I’ve told my children to follow you into your hundreds , I’ll be gone by then but I believe you may find a way to 2100 and beyond

@bryan_johnson Why do we want to solve death to begin with?

On the other hand I'm afraid that very soon all AI-behemoths are going to limit the availability of their mostly advanced AI models to the wide public and also all academic scientists and other biotech companies,
just because they want to become the best and first ones in the competition of finding the first groundbreaking longevity drug.
Just look around, what is happening in the world right now, Bryan.
Your biggest strength in business has been always your very good "seventh sense" in analyzing and predicting all trends.
Can't you see it coming that the increasing competition among our wealthiest billionaires and biggest AI-powers will soon divide our entire world,
and also limit the natural development of humanity's science (because of drained public AI models)
just because everybody wants to win the longevity race, and establish their leading power in the longevity space?
Doesn't it seem to your sensitive and humanitarian soul, that our entire world is heading already in a "too mad" direction, @bryan_johnson?
And meanwhile all this happens, none of our most powerful and most influental billionaires and politicians are noticing that our entire civilization is running towards our collective extinction,
while everybody is chasing individual wealth and individual longevity,
instead of trying to stop the climate crisis with joint efforts.

@bryan_johnson After Death 1 has been solved we will have to solve Death 2. Death 2 is low probability causes of death: random freak accidents, asteroids, gamma radiation blasting us incoming from another part of the galaxy, information hazards that break minds. Then Death 3 must be solved.

@rohanpaul_ai tbh claude code by itself is a drug and I'm addicted to it ;)

@bryan_johnson Do you have thanatophobia?

@MikeDoris @bryan_johnson Aging is a neglected disease and Dario is supportive of life extension in humans.
Slowing and reversing aging solves a lot of diseases of aging.
https://observer.com/2025/01/anthropic-dario-amodei-ai-advances-double-human-lifespans/

@bryan_johnson @grok how old is Dario Amodei?

@bryan_johnson They absolutely should. This is the best use case for LLMs..if we done nothing with AI other than this It will still be a huge win.

@bryan_johnson Please Son of God help me When the president of the United States Donald Trump said that he will attack Nigeria and many people denied it, was said that there is peace in Nigeria and it is a lie,

@bryan_johnson They need a better name. Should have been Cyberdyne....

@bryan_johnson Biology is just legacy code we haven't fully reverse engineered yet. AI is about to become the ultimate decompiler

@bryan_johnson If we cure death and aging, it seems fairly logical that overpopulation would result. how do you think we should deal with that?

@bryan_johnson What do you think the world will look like post-AGI and post-Death?

@samuellawrentz 👊💯